Zealand University Hospital
356
66
80
159
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.8%
17 terminated/withdrawn out of 356 trials
90.3%
+3.8% vs industry average
13%
47 trials in Phase 3/4
3%
4 of 159 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (356)
PERCUTANEOUS EMBOLECTOMY, ULTRASOUND ASSISTED LOW DOSE THROMBOLYSIS OR HEPARIN FOR INTERMEDIATE HIGH RISK PULMONARY EMBOLISM (STRATIFY II)
Role: collaborator
Physical Recovery During Bracing After Ankle Fracture (Re-BAF)
Role: collaborator
Prospective Surveillance for Breast Cancer-Related Lymphedema
Role: collaborator
Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)
Role: lead
Inforatio Technique to Promote Wound Healing of Diabetic Foot Ulcers
Role: lead
CAPTURE-HFpEF: National Study of Identification and Phenotyping of Heart Failure With Preserved Ejection Fraction
Role: collaborator
The Connect Trial: Connecting Hospital Patients to Alcohol Care
Role: lead
Prevention of Preeclampsia in Denmark: A National Implementation Study
Role: collaborator
The Intensive Care Platform Trial
Role: collaborator
Digitizing Cancer Rehabilitation During and After Systemic Treatment: Feasibility Testing Implementation in South Baltic Countries
Role: lead
NORTH-REG Dwell-Time Study
Role: collaborator
Sonoporation and Tumor Microenvironment Response in Colorectal Liver Metastases
Role: lead
Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.
Role: collaborator
Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer
Role: collaborator
Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy
Role: collaborator
Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer
Role: collaborator
Local Antibiotics for Breast Implants
Role: collaborator
Sarcopenia and Cachexia in Patients With Lung Cancer
Role: lead
Carbergoline for Antipsychotic Induced Hyperprolactinemia.
Role: lead
Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer
Role: lead